|
Volumn 119, Issue 3, 2002, Pages 877-878
|
Clinicopathological correlation, p16-p15 methylation status and outcome predictors in anaplastic large cell lymphoma [3]
|
Author keywords
ALCL; ALK; Outcome; P16INK4a p15INK4b methylation; TIA
|
Indexed keywords
ANAPLASTIC LYMPHOMA KINASE;
ANTIBODY;
BIOCHEMICAL MARKER;
CD30 ANTIGEN;
NUCLEOPHOSMIN;
PROTEIN P15;
PROTEIN P16;
T LYMPHOCYTE ANTIGEN;
ADOLESCENT;
ADULT;
AGE;
AGED;
ANTIGEN EXPRESSION;
B CELL LYMPHOMA;
CHILD;
CLINICAL FEATURE;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DISEASE COURSE;
DISEASE MARKER;
FEMALE;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOLOGY;
KAPLAN MEIER METHOD;
LARGE CELL LYMPHOMA;
LETTER;
LOGISTIC REGRESSION ANALYSIS;
MAJOR CLINICAL STUDY;
MALE;
METHYLATION;
MORTALITY;
MULTIVARIATE ANALYSIS;
PATHOLOGY;
PERIPHERAL T CELL LYMPHOMA;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN EXPRESSION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
RNA ISOLATION;
SURVIVAL;
ADOLESCENT;
ADULT;
CHILD;
CHILD, PRESCHOOL;
DNA METHYLATION;
FEMALE;
GENE REARRANGEMENT;
HUMANS;
INFANT;
LYMPHOMA, LARGE-CELL;
MALE;
MIDDLE AGED;
NEOPLASM PROTEINS;
PROGNOSIS;
PROTEIN-TYROSINE KINASES;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0036433525
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2002.03870_3.x Document Type: Letter |
Times cited : (8)
|
References (5)
|